Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Corlopam
2. Fenoldopam
3. Fenoldopam Hydrobromide
4. Hydrobromide, Fenoldopam
5. Sk And F 82526
6. Sk And F 82526j
7. Sk And F-82526
8. Sk And F-82526j
9. Sk And F82526
10. Sk And F82526j
11. Skf 82526
12. Skf 82526j
13. Skf-82526
14. Skf-82526j
15. Skf82526
16. Skf82526j
1. 67227-57-0
2. Corlopam
3. Fenoldopam Methanesulfonate
4. Fenoldopam (mesylate)
5. Fenoldopam Mesilate
6. Corlopam Mesylate
7. Sk&f 82526-j
8. Fendolopam Mesylate
9. Nsc-759860
10. 9-chloro-5-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1h-3-benzazepine-7,8-diol;methanesulfonic Acid
11. Ha3r0my016
12. Sk&f-82526j
13. 6-chloro-2,3,4,5-tetrahydro-1-(p-hydroxyphenyl)-1h-3-benzazepine-7,8-diol Methanesulfonate (salt)
14. Fenoldopam Methanesulfonate;skf-82526 Mesylate
15. 9-chloro-5-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1h-3-benzazepine-7,8-diol,methanesulfonic Acid
16. 1h-3-benzazepine-7,8-diol, 6-chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-, Methanesulfonate (salt)
17. Mls001401388
18. 6-chloro-1-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1h-benzo[d]azepine-7,8-diol Methanesulfonate
19. Einecs 266-612-7
20. Fenoldopam Mesylate [usan]
21. 6-chloro-1-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1h-3-benzazepine-7,8-diol; Methanesulfonic Acid
22. Fenoldopam Monomethanesulfonate
23. Sk-82526-j
24. Skf 82526-j
25. Smr000469190
26. Unii-ha3r0my016
27. Skf 82526 (mesylate)
28. Fenoldopam Mesylate [usan:usp]
29. Corlopam (tn)
30. Skf-82526 Mesylate
31. Fenoldopam Mesylate (usp)
32. Chembl1026
33. Schembl41213
34. 6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-(p-hydroxyphenyl)-1h-3-benzazepinium Methanesulphonate
35. 9-chloro-5-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1h-3-benzazepine-7,8-diol; Methanesulfonic Acid
36. Chebi:5003
37. Hy-b0735a
38. Dtxsid00904650
39. Hms2051p09
40. Hms2230j03
41. Hms3264b10
42. Hms3371l12
43. Hms3393p09
44. Hms3885l10
45. Pharmakon1600-01505539
46. Fenoldopam Mesylate [vandf]
47. Fenoldopam Mesilate [mart.]
48. Fenoldopam Mesilate [who-dd]
49. Fenoldopam Mesylate [usp-rs]
50. Nsc759860
51. S4618
52. Sk&f-82526-j
53. Akos030254549
54. Fenoldopam Mesylate, >=98% (hplc)
55. Ccg-100942
56. Ccg-213480
57. M27f569
58. Nc00192
59. Nsc 759860
60. Fenoldopam Methanesulfonate [mi]
61. Fenoldopam Mesylate [orange Book]
62. Ac-32753
63. As-57125
64. Fenoldopam Mesylate [usp Monograph]
65. Db-054999
66. Ft-0626401
67. C76117
68. D00613
69. A835665
70. W-104725
71. Q27279818
72. Z2210694608
73. Fenoldopam Mesylate, United States Pharmacopeia (usp) Reference Standard
74. 6-chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-1h-3-benzazepine-7,8-diol Mesylate
75. 1h-3-benzazepine-7,8-diol, 6-chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-, Methanesulphonate (salt)
76. 6-chloro-1-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1h-3-benzazepine-7,8-diol;methanesulfonic Acid
77. 6-chloro-2,3,4,5-tetrahydro-1-(p-hydroxyphenyl)-1h-3-benzazepine-7,8-diol Methanesulphonate (salt)
78. 6-chloro-7,8-dihydroxy-1-(p-hydroxyphenyl)-2,3,4,5-tetrahydro-1h-3-benzazepine Methane Sulfonate
Molecular Weight | 401.9 g/mol |
---|---|
Molecular Formula | C17H20ClNO6S |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 1 |
Exact Mass | 401.0699862 g/mol |
Monoisotopic Mass | 401.0699862 g/mol |
Topological Polar Surface Area | 136 Ų |
Heavy Atom Count | 26 |
Formal Charge | 0 |
Complexity | 441 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Corlopam |
PubMed Health | Fenoldopam (Injection) |
Drug Classes | Antihypertensive |
Drug Label | Corlopam (Fenoldopam Mesylate Injection, USP) is a dopamine D1-like receptor agonist. The product is formulated as a solution to be diluted for intravenous infusion. Chemically it is 6-chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-[1H]-3-benzazepine-... |
Active Ingredient | Fenoldopam mesylate |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 10mg base/ml |
Market Status | Prescription |
Company | Hospira |
2 of 4 | |
---|---|
Drug Name | Fenoldopam mesylate |
Drug Label | Fenoldopam Mesylate Injection, USP is a dopamine D1-like receptor agonist. The product is formulated as a solution to be diluted for intravenous infusion. Chemically it is 6-chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-[1H]-3-benzazepine-7,8-diol me... |
Active Ingredient | Fenoldopam mesylate |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 10mg base/ml |
Market Status | Prescription |
Company | Eurohlth Intl; Sandoz |
3 of 4 | |
---|---|
Drug Name | Corlopam |
PubMed Health | Fenoldopam (Injection) |
Drug Classes | Antihypertensive |
Drug Label | Corlopam (Fenoldopam Mesylate Injection, USP) is a dopamine D1-like receptor agonist. The product is formulated as a solution to be diluted for intravenous infusion. Chemically it is 6-chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-[1H]-3-benzazepine-... |
Active Ingredient | Fenoldopam mesylate |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 10mg base/ml |
Market Status | Prescription |
Company | Hospira |
4 of 4 | |
---|---|
Drug Name | Fenoldopam mesylate |
Drug Label | Fenoldopam Mesylate Injection, USP is a dopamine D1-like receptor agonist. The product is formulated as a solution to be diluted for intravenous infusion. Chemically it is 6-chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-[1H]-3-benzazepine-7,8-diol me... |
Active Ingredient | Fenoldopam mesylate |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 10mg base/ml |
Market Status | Prescription |
Company | Eurohlth Intl; Sandoz |
Antihypertensive Agents
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
Dopamine Agonists
Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
Related Excipient Companies
Excipients by Applications
Global Sales Information
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?